FUTURE WEBINAR - 2026, Tuesday January 13th - “Arm in arm: CM&S and AI support coronary artery disease diagnostics”
CLICK HERE TO REGISTER
At Hemolens Diagnostics®, our mission is to transform the diagnosis and management of coronary artery disease (CAD) through innovative, non-invasive technologies that improve patient outcomes and support efficient healthcare delivery. Driven by the vision of making advanced diagnostics a global standard, we have developed the Cardiolens® Platform—a comprehensive solution powered by a proprietary triple engine integrating Artificial Intelligence (AI), Biomechanical Engineering (BME), and Computational Fluid Dynamics (CFD). This synergy enables precise, patient-specific coronary artery analysis from CT imaging. During the presentation, we will introduce our flagship product, Cardiolens FFR-CT Pro, an advanced diagnostic tool that reconstructs the coronary lumen from CT scans and applies in silico modeling techniques to non-invasively evaluate ischemic risk.
